We report the detection of a plasmid-borne mobile colistin-resistance-gene, mcr-1, in Proteus mirabilis, a known community and hospital pathogen, that was isolated from a toddler (2 years old) in the community in Lebanon. To our knowledge, this is the first report of the occurrence of mcr-1 in humanassociated P. mirabilis as well as mcr-1 in humans in the Lebanese community.
Introduction
The recent discovery and global dissemination of mobile genetic elements (mcr) that can confer colistin (polymyxin E) resistance have jeopardized the efficacy of this last resort antibiotic and raised public health concerns [1, 2] . The spread of mcr might be most problematic in countries with limited resources and developing antimicrobial stewardship [3] . Previously, we have described the use of colistin in medicine and agriculture and documented the prevalence of mcr-1 in multidrug-resistant Escherichia coli in different matrices in Lebanon [4] [5] [6] . However, sources and transmission of mcr remain largely uncharacterized in Lebanon, especially in relation to the human population. Therefore, we initiated surveillance efforts in order to better understand the molecular epidemiology of mcr in Lebanon.
Case report
During routine screening of fecal matter collected from diapers of 2-year-old toddlers in the community, we identified whitish and irregularly shaped colonies on RAPID'E.coli 2 agar supplemented with 4 mg/ml colistin [4] [5] [6] . A colony (LB-SH32) was further purified and appeared colorless and unable to ferment lactose on MacConkey agar but had distinctive "fishy" odor. PCR analysis showed that LB-SH32 was positive for a species-specific urease gene (ureC) fragment, which identified the isolate as Proteus mirabilis [7] , a Gram-negative enteric bacterium that most commonly causes urinary tract infections but may also lead to respiratory tract-, wound-and other infections. Minimum inhibitory concentration (MIC) analysis showed that LB-SH32 was highly resistant to colistin (MIC > 4096 mg/ml), indicating that the isolate was intrinsically colistin-resistant as expected for P. mirabilis [8] . However, the isolate was mcr-1-positive (mcr-2 to 8-negative), which was confirmed by commercial sequencing. Heat shock transformation with plasmids extracted from LB-SH32 resulted in the successful introduction of the mcr-1 into chemically-competent E. coli JM109, indicating that the mcr-1 was plasmid-borne and transmissible to other bacteria. The transformants were also resistant to colistin (MIC 8 mg/ml). Typing showed that the plasmids belonged to IncP1-alpha, which has a broad-host range, can transfer and replicate in different Gram-negative bacteria, and can transmit resistance genes [9, 10] . LB-SH32 was multidrug-resistant, displaying resistance to amoxicillin-calvulanic acid, cephalexin, imipenem, gentamicin, kanamycin, streptomycin, tetracycline, and trimethoprim-sulfamethoxazole, while harboring genes encoding beta-lactamase (bla TEM-1 , bla NDM-1 , bla KPC ), tetracycline
Discussion
This is the first report of 1) transmissible plasmid-borne mcr-1 in P. mirabilis from humans and 2) the detection of mcr-1 in the Lebanese population. During the peer-review assessment of this study, a manuscript reported the detection of mcr-1 in six clinical E. coli isolates of human origins in Lebanon [11] . Also, as previously mentioned, our study targeted the Lebanese population at large and was conducted on the level of the community in a non-clinical setting. Because P. mirabilis is intrinsically colistin resistant, this pathogen is often not screened for mcr. However, our study shows that P. mirabilis can serve as reservoir for the transmission of these genes to colistin-susceptible bacteria. Therefore, the overlooked role of P. mirabilis might be important to further understand the epidemiology and dissemination of mcr.
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